FDA FDA Issues Untitled Letter to Althera Over Roszet Promotions Thomas Sullivan Aug 24, 2022 0 In early June 2022, the United States Food and Drug Administration (FDA) sent an Untitled Letter to Althera Pharmaceuticals, LLC,…
